CrossrefInfokarte
An Update on Xanomeline-trospium (Cobenfy) for Schizophrenia: Emerging Evidence and Clinical Implications
Clinical Psychopharmacology and Neuroscience · 2026-11-30 · 24 (4) · 692-700
DOI: 10.9758/cpn.26.1406 ↗Abstract
Kein Abstract verfügbar.
EUVIMED